Terms: = Liver cancer AND TPM3, ENSG00000143549, 7170 AND Treatment
8 results:
1. Vincristine/irinotecan/temsirolimus upfront window treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 Study Committee.
Thompson PA; Malogolowkin MH; Furman WL; Piao J; Krailo MD; Chung N; Brock L; Towbin AJ; McCarville EB; Finegold MJ; Ranganathan S; Dunn SP; Langham MR; McGahren ED; Tiao GM; Weldon CB; O'Neill AF; Rodriguez-Galindo C; Meyers RL; Katzenstein HM
Pediatr Blood Cancer; 2023 Jul; 70(7):e30365. PubMed ID: 37073741
[TBL] [Abstract] [Full Text] [Related]
2. Gd-EOB-DTPA-enhanced MRI-a noninvasive and short-term assessment method for liver necroinflammation after direct-acting antiviral (DAA) therapy in patients with chronic hepatitis C.
Li A; Wu J; Cheng J; Feng C; Liu W; Li Y; Rao H; Huang R; Zhou G; Hong N; Wang Y
Abdom Radiol (NY); 2022 Jan; 47(1):174-183. PubMed ID: 34664096
[TBL] [Abstract] [Full Text] [Related]
3. Establishment of Prognostic Nomograms for Predicting the Survival of HR-Positive, HER2-Negative Metastatic Breast cancer Patients Treated with Everolimus.
Duan F; Song C; Ma Y; Jiang K; Xu F; Bi X; Huang J; Hong R; Huang Z; Lu Q; Yuan Z; Wang S; Xia W
Drug Des Devel Ther; 2021; 15():3463-3473. PubMed ID: 34408400
[TBL] [Abstract] [Full Text] [Related]
4. Foretinib Overcomes Entrectinib Resistance Associated with the
Nishiyama A; Yamada T; Kita K; Wang R; Arai S; Fukuda K; Tanimoto A; Takeuchi S; Tange S; Tajima A; Furuya N; Kinoshita T; Yano S
Clin Cancer Res; 2018 May; 24(10):2357-2369. PubMed ID: 29463555
[No Abstract] [Full Text] [Related]
5. In vivo imaging xenograft models for the evaluation of anti-brain tumor efficacy of targeted drugs.
Kita K; Arai S; Nishiyama A; Taniguchi H; Fukuda K; Wang R; Yamada T; Takeuchi S; Tange S; Tajima A; Nakada M; Yasumoto K; Motoo Y; Murakami T; Yano S
Cancer Med; 2017 Dec; 6(12):2972-2983. PubMed ID: 29125233
[TBL] [Abstract] [Full Text] [Related]
6. A New treatment-integrated Prognostic Nomogram of the Barcelona Clinic liver cancer System for Hepatocellular Carcinoma.
Hsu CY; Liu PH; Hsia CY; Lee YH; Nagaria TS; Lee RC; Ho SY; Hou MC; Huo TI
Sci Rep; 2017 Aug; 7(1):7914. PubMed ID: 28801646
[TBL] [Abstract] [Full Text] [Related]
7. Proteomic analysis of hepatocellular carcinoma HepG2 cells treated with platycodin D.
Lu JJ; Lu DZ; Chen YF; Dong YT; Zhang JR; Li T; Tang ZH; Yang Z
Chin J Nat Med; 2015 Sep; 13(9):673-9. PubMed ID: 26412427
[TBL] [Abstract] [Full Text] [Related]
8. Identification and characterization of tropomyosin 3 associated with granulin-epithelin precursor in human hepatocellular carcinoma.
Lam CY; Yip CW; Poon TC; Cheng CK; Ng EW; Wong NC; Cheung PF; Lai PB; Ng IO; Fan ST; Cheung ST
PLoS One; 2012; 7(7):e40324. PubMed ID: 22792281
[TBL] [Abstract] [Full Text] [Related]
